|
Clarification to h.6.Type of investigation code: the filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.The event is a physiological complication and analysis of the device generally does not assist abbvie in determining a probable cause for this event.Further information regarding event, product, or patient details has been requested.No additional information is available at this time.A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.This is a known potential adverse event addressed in the product labeling.
|
|
Healthcare professional reported injecting a patient in the nasolabial folds and marionette lines with 2 syringes of juvéderm vollure¿ xc.Six months later, the patient was injected in the nasolabial folds with 1 syringe of juvéderm vollure¿ xc.Twenty-one months later, the patient experienced ¿pain, swelling, and nodules¿ in the nasolabial folds and marionette lines.An ultrasound was performed by a dermatologist, where no cysts were found.Four months after onset, the patient contacted the injecting healthcare professional and was treated with hylenex.More hylenex was given 12 days later, again 2 days later, a week later, five days later, and two days later.The event achieved 90% clearance.Event is ongoing.This file captured the additional injection.
|